Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebral arteritis in scleroderma.

E Estey, A Lieberman, R Pinto

    Stroke
    |September 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression.

    Nature communications·2018
    Same author

    Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed?

    Leukemia·2017
    Same author

    A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.

    Leukemia·2017
    Same author

    How good are we at predicting the fate of someone with acute myeloid leukaemia?

    Leukemia·2017
    Same author

    Acute myeloid leukemia therapy and the chosen people.

    Leukemia·2016
    Same author

    A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.

    Leukemia·2016
    Same journal

    Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association.

    Stroke·2026
    Same journal

    Update on Rehabilitation After Stroke: Global Changes and the Continued Importance of Therapy Intensity, Dose, and Timing.

    Stroke·2026
    Same journal

    ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis.

    Stroke·2026
    Same journal

    Menopause and Its Implications for Stroke in Women.

    Stroke·2026
    Same journal

    Physician Approaches to Determining Goals of Stroke Care for Patients Living With Disability or Dementia: Results from the SEED Mixed-Methods Study.

    Stroke·2026
    Same journal

    Aspirin for Stroke Primary Prevention: A Step Toward Genetic-Driven Personalized Medicine.

    Stroke·2026
    See all related articles

    Central nervous system (CNS) involvement in scleroderma is uncommon. This case highlights that cerebral arteritis can occur in scleroderma, even without other organ issues, and may respond to corticosteroids.

    Area of Science:

    • Neurology
    • Rheumatology
    • Vascular Medicine

    Background:

    • Scleroderma, a connective tissue disease, rarely affects the central nervous system (CNS).
    • CNS involvement typically occurs with concurrent renal, lung, or severe hypertension issues.
    • The rarity of isolated CNS manifestations in scleroderma makes such cases diagnostically challenging.

    Observation:

    • A 43-year-old woman with established scleroderma presented with subacute encephalopathy.
    • The patient had no concurrent renal or lung abnormalities or malignant hypertension.
    • Cerebral angiography revealed focal arteritis, suggesting a vascular cause for the neurological symptoms.

    Findings:

    • The patient's encephalopathy improved significantly with corticosteroid treatment.

    Related Experiment Videos

  • This clinical response suggests an inflammatory or autoimmune basis for the cerebral arteritis.
  • The case demonstrates that scleroderma-associated cerebral arteritis can manifest independently.

    • Implications:

    • Cerebral arteritis should be considered in scleroderma patients with unexplained neurological symptoms, even without systemic complications.
    • Early diagnosis and treatment with corticosteroids may improve outcomes in such cases.
    • This finding expands the spectrum of potential CNS manifestations in scleroderma.